Carcinogenesis, Vol. 22, No. 4, 593-597,
April 2001
© 2001 Oxford University Press
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION |
Genetic polymorphisms in DNA repair genes and risk of lung cancer
Department of Tumor Biology, Centre of Oncology, M.Sklodowska-Curie Memorial Institute, 44–101 Gliwice, Poland,
1 Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007 and
2 Laboratory of Human Carcinogenesis, Division of Basic Science, National Cancer Institute, NIH, 37 Convent Drive, Building 37, Room 2C05, Bethesda, MD 20892-4255, USA
Polymorphisms in DNA repair genes may be associated with differences in the repair efficiency of DNA damage and may influence an individual's risk of lung cancer. The frequencies of several amino acid substitutions in XRCC1 (Arg194Trp, Arg280His and Arg399Gln), XRCC3 (Thr241Met), XPD (Ile199Met, His201Tyr, Asp312Asn and Lys751Gln) and XPF (Pro379Ser) genes were studied in 96 non-small-cell lung cancer (NSCLC) cases and in 96 healthy controls matched for age, gender and cigarette smoking. The XPD codon 312 Asp/Asp genotype was found to have almost twice the risk of lung cancer when the Asp/Asn + Asn/Asn combined genotype served as reference [odds ratio (OR) 1.86, 95% confidence interval (CI), 1.02–3.40]. In light cigarette smokers (less than the median of 34.5 pack-years), the XPD codon 312 Asp/Asp genotype was more frequent among cases than in controls and was associated with an increased risk of NSCLC. Compared with the Asn/Asn carriers, the OR in light smokers with the Asp/Asn genotype was 1.70 (CI0.35 0.43–6.74) and the OR in those with the Asp/Asp genotype was 5.32 (CI0.35–21.02) (P trend = 0.01). The 312 Asp/Asp genotype was not associated with lung cancer risk in never-smokers or heavy smokers (>34.5 pack-years). The XPD-312Asp and -751Lys polymorphisms were in linkage disequilibrium in the group studied; this finding was further supported by pedigree analysis of four families from Utah. The XPD 312Asp amino acid is evolutionarily conserved and is located in the seven-motif helicase domain of the RecQ family of DNA helicases. Our results indicate that these polymorphisms in the XPD gene should be investigated further for the possible attenuation of DNA repair and apoptotic functions and that additional molecular epidemiological studies are warranted to extend these findings.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Cheng, S. Leng, H. Li, C. Huang, Y. Niu, L. Zhang, X. Liang, H. Lin, and Y. Zheng Suboptimal DNA Repair Capacity Predisposes Coke-Oven Workers To Accumulate More Chromosomal Damages in Peripheral Lymphocytes Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 987 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. McWilliams, W. R. Bamlet, J. M. Cunningham, E. L. Goode, M. de Andrade, L. A. Boardman, and G. M. Petersen Polymorphisms in DNA Repair Genes, Smoking, and Pancreatic Adenocarcinoma Risk Cancer Res., June 15, 2008; 68(12): 4928 - 4935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wang, D. Chang, F.-l. Hu, H. Sui, B. Han, D.-d. li, and Y.-s. Zhao DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 507 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Crew, M. D. Gammon, M. B. Terry, F. F. Zhang, L. B. Zablotska, M. Agrawal, J. Shen, C.-M. Long, S. M. Eng, S. K. Sagiv, et al. Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2033 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Qiu, S. Leng, Z. Wang, Y. Dai, Y. Zheng, and Z. Wang Path Analysis of Biomarkers of Exposure and Early Biological Effects among Coke-Oven Workers Exposed to Polycyclic Aromatic Hydrocarbons Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1193 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Quintela-Fandino, R. Hitt, P. P. Medina, S. Gamarra, L. Manso, H. Cortes-Funes, and M. Sanchez-Cespedes DNA-Repair Gene Polymorphisms Predict Favorable Clinical Outcome Among Patients With Advanced Squamous Cell Carcinoma of the Head and Neck Treated With Cisplatin-Based Induction Chemotherapy J. Clin. Oncol., September 10, 2006; 24(26): 4333 - 4339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Hu, L. Xu, M. Shao, J. Yuan, Y. Wang, F. Wang, W. Yuan, J. Qian, H. Ma, Y. Wang, et al. Polymorphisms in the Two Helicases ERCC2/XPD and ERCC3/XPB of the Transcription Factor IIH Complex and Risk of Lung Cancer: A Case-Control Analysis in a Chinese Population. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1336 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matullo, A.M. Dunning, S. Guarrera, C. Baynes, S. Polidoro, S. Garte, H. Autrup, C. Malaveille, M. Peluso, L. Airoldi, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study Carcinogenesis, May 1, 2006; 27(5): 997 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Andrew, H. H. Nelson, K. T. Kelsey, J. H. Moore, A. C. Meng, D. P. Casella, T. D. Tosteson, A. R. Schned, and M. R. Karagas Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility Carcinogenesis, May 1, 2006; 27(5): 1030 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bigler, C. M. Ulrich, T. Kawashima, J. Whitton, and J. D. Potter DNA Repair Polymorphisms and Risk of Colorectal Adenomatous or Hyperplastic Polyps Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2501 - 2508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matullo, S. Guarrera, C. Sacerdote, S. Polidoro, L. Davico, S. Gamberini, M. Karagas, G. Casetta, L. Rolle, A. Piazza, et al. Polymorphisms/Haplotypes in DNA Repair Genes and Smoking: A Bladder Cancer Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2569 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Silva, O. M. Gil, V. C. Oliveira, M. N. Cabral, A. P. Azevedo, A. Faber, I. Manita, T. C. Ferreira, E. Limbert, J. E. Pina, et al. Association of Polymorphisms in ERCC2 Gene with Non-Familial Thyroid Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2407 - 2412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Casson, Z. Zheng, S. C. Evans, P. J. Veugelers, G. A. Porter, and D. L. Guernsey Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma Carcinogenesis, September 1, 2005; 26(9): 1536 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Marsit, J. K. Wiencke, M. Liu, and K. T. Kelsey The race associated allele of Semaphorin 3B (SEMA3B) T415I and its role in lung cancer in African-Americans and Latino-Americans Carcinogenesis, August 1, 2005; 26(8): 1446 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Hu, H. Ma, F. Chen, Q. Wei, and H. Shen XRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1810 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kyoizumi, Y. Kusunoki, T. Hayashi, M. Hakoda, J. B. Cologne, and K. Nakachi Individual Variation of Somatic Gene Mutability in Relation to Cancer Susceptibility: Prospective Study on Erythrocyte Glycophorin A Gene Mutations of Atomic Bomb Survivors Cancer Res., June 15, 2005; 65(12): 5462 - 5469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Leng, J. Cheng, L. Zhang, Y. Niu, Y. Dai, Z. Pan, B. Li, F. He, and Y. Zheng The Association of XRCC1 Haplotypes and Chromosomal Damage Levels in Peripheral Blood Lymphocyte among Coke-Oven Workers Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1295 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Schabath, G. L. Delclos, H. B. Grossman, Y. Wang, S. P. Lerner, R. M. Chamberlain, M. R. Spitz, and X. Wu Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Mechanic, A. J. Marrogi, J. A. Welsh, E. D. Bowman, M. A. Khan, L. Enewold, Y.-L. Zheng, S. Chanock, P. G. Shields, and C. C. Harris Polymorphisms in XPD and TP53 and mutation in human lung cancer Carcinogenesis, March 1, 2005; 26(3): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Benhamou and A. Sarasin ERCC2 /XPD Gene Polymorphisms and Lung Cancer: A HuGE Review Am. J. Epidemiol., January 1, 2005; 161(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pavanello, A. Pulliero, E. Siwinska, D. Mielzynska, and E. Clonfero Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers Carcinogenesis, January 1, 2005; 26(1): 169 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Terry, M. D. Gammon, F. F. Zhang, S. M. Eng, S. K. Sagiv, A. B. Paykin, Q. Wang, S. Hayes, S. L. Teitelbaum, A. I. Neugut, et al. Polymorphism in the DNA Repair Gene XPD, Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2053 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Justenhoven, U. Hamann, B. Pesch, V. Harth, S. Rabstein, C. Baisch, C. Vollmert, T. Illig, Y.-D. Ko, T. Bruning, et al. ERCC2 Genotypes and a Corresponding Haplotype Are Linked with Breast Cancer Risk in a German Population Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2059 - 2064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Aspen Cancer Conference Fellows Toxicol Pathol, October 1, 2004; 32(6): 749 - 761. [PDF]
|
|
|
|
|
|
L.-E Wang, M. L. Bondy, H. Shen, R. El-Zein, K. Aldape, Y. Cao, V. Pudavalli, V. A. Levin, W. K. A. Yung, and Q. Wei Polymorphisms of DNA Repair Genes and Risk of Glioma Cancer Res., August 15, 2004; 64(16): 5560 - 5563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ito, K. Matsuo, N. Hamajima, T. Mitsudomi, T. Sugiura, T. Saito, T. Yasue, K.-M. Lee, D. Kang, K.-Y. Yoo, et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk Carcinogenesis, August 1, 2004; 25(8): 1395 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhou, S. Gurubhagavatula, G. Liu, S. Park, D. S. Neuberg, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy Clin. Cancer Res., August 1, 2004; 10(15): 4939 - 4943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gurubhagavatula, G. Liu, S. Park, W. Zhou, L. Su, J. C. Wain, T. J. Lynch, D. S. Neuberg, and D. C. Christiani XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non--Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy J. Clin. Oncol., July 1, 2004; 22(13): 2594 - 2601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Figueiredo, J. A. Knight, L. Briollais, I. L. Andrulis, and H. Ozcelik Polymorphisms XRCC1-R399Q and XRCC3-T241M and the Risk of Breast Cancer at the Ontario Site of the Breast Cancer Family Registry Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 583 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-M. Gao, M. Romkes, J. M. Siegfried, J. D. Luketich, and P. Keohavong No Association between the XPD 312, 751, or XRCC1 399 Polymorphisms and K-ras Gene Mutation in Smoking Non-Small-Cell Lung Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 673 - 675. [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology Cancer Res., March 15, 2004; 64(6): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Han, S. E. Hankinson, H. Ranu, I. De Vivo, and D. J. Hunter Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study Carcinogenesis, February 1, 2004; 25(2): 189 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-O. Shu, Q. Cai, Y.-T. Gao, W. Wen, F. Jin, and W. Zheng A Population-Based Case-Control Study of the Arg399Gln Polymorphism in DNA Repair Gene XRCC1 and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1462 - 1467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Moullan, D. G. Cox, S. Angele, P. Romestaing, J.-P. Gerard, and J. Hall Polymorphisms in the DNA Repair Gene XRCC1, Breast Cancer Risk, and Response to Radiotherapy Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1168 - 1174. [Abstract] [Full Text]
|
|
|
|
|
|
W.-M. Gao, M. Romkes, R. D. Day, J. M. Siegfried, J. D. Luketich, H. H. Mady, M. F. Melhem, and P. Keohavong Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer Carcinogenesis, October 1, 2003; 24(10): 1671 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gackowski, E. Speina, M. Zielinska, J. Kowalewski, R. Rozalski, A. Siomek, T. Paciorek, B. Tudek, and R. Olinski Products of Oxidative DNA Damage and Repair as Possible Biomarkers of Susceptibility to Lung Cancer Cancer Res., August 15, 2003; 63(16): 4899 - 4902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Medina, S. A. Ahrendt, M. Pollan, P. Fernandez, D. Sidransky, and M. Sanchez-Cespedes Screening of Homologous Recombination Gene Polymorphisms in Lung Cancer Patients Reveals an Association of the NBS1-185Gln Variant and p53 Gene Mutations Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 699 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matullo, M. Peluso, S. Polidoro, S. Guarrera, A. Munnia, V. Krogh, G. Masala, F. Berrino, S. Panico, R. Tumino, et al. Combination of DNA Repair Gene Single Nucleotide Polymorphisms and Increased Levels of DNA Adducts in a Population-based Study Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 674 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Nexo, U. Vogel, A. Olsen, T. Ketelsen, Z. Bukowy, B. L. Thomsen, H. Wallin, K. Overvad, and A. Tjonneland A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55 Carcinogenesis, May 1, 2003; 24(5): 899 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Polymorphisms in the DNA Repair Genes XRCC1 and ERCC2, Smoking, and Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 359 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, H. Zhao, Q. Wei, C. I. Amos, K. Zhang, Z. Guo, Y. Qiao, W. K. Hong, and M. R. Spitz XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity Carcinogenesis, March 1, 2003; 24(3): 505 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Goode, C. M. Ulrich, and J. D. Potter Polymorphisms in DNA Repair Genes and Associations with Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1513 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yin, E. Rockenbauer, M. Hedayati, N. R. Jacobsen, U. Vogel, L. Grossman, L. Bolund, and B. A. Nexo Multiple Single Nucleotide Polymorphisms on Human Chromosome 19q13.2-3 Associate with Risk of Basal Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1449 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Benhamou and A. Sarasin ERCC2/XPD gene polymorphisms and cancer risk Mutagenesis, November 1, 2002; 17(6): 463 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Shields Tobacco Smoking, Harm Reduction, and Biomarkers J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Stern, L. R. Johnson, D. A. Bell, and J. A. Taylor XPD Codon 751 Polymorphism, Metabolism Genes, Smoking, and Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1004 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Duan, H. Shen, J. E. Lee, J. E. Gershenwald, M. I. Ross, P. F. Mansfield, M. Duvic, S. S. Strom, M. R. Spitz, and Q. Wei DNA Repair Gene XRCC3 241Met Variant Is Not Associated with Risk of Cutaneous Malignant Melanoma Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1142 - 1143. [Full Text] [PDF]
|
|
|
|
 |
|
 W J Lemon, H Bernert, H Sun, Y Wang, and M You Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays J. Med. Genet., September 1, 2002; 39(9): 644 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Sturgis, K. R. Dahlstrom, M. R. Spitz, and Q. Wei DNA Repair Gene ERCC1 and ERCC2/XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck Arch Otolaryngol Head Neck Surg, September 1, 2002; 128(9): 1084 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Rockenbauer, M. H. Bendixen, Z. Bukowy, J. Yin, N. R. Jacobsen, M. Hedayati, U. Vogel, L. Grossman, L. Bolund, and B. A. Nexo Association of chromosome 19q13.2-3 haplotypes with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts Carcinogenesis, July 1, 2002; 23(7): 1149 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tuimala, G. Szekely, S. Gundy, A. Hirvonen, and H. Norppa Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity Carcinogenesis, June 1, 2002; 23(6): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Taylor, A. Thistlethwaite, and K. W. Caldecott Central Role for the XRCC1 BRCT I Domain in Mammalian DNA Single-Strand Break Repair Mol. Cell. Biol., April 15, 2002; 22(8): 2556 - 2563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Gene-Environment Interaction for the ERCC2 Polymorphisms and Cumulative Cigarette Smoking Exposure in Lung Cancer Cancer Res., March 1, 2002; 62(5): 1377 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Qiao, M. R. Spitz, H. Shen, Z. Guo, S. Shete, M. Hedayati, L. Grossman, H. Mohrenweiser, and Q. Wei Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes Carcinogenesis, February 1, 2002; 23(2): 295 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman and W. Ki Hong Cancer Prevention by Delay : Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002. Clin. Cancer Res., February 1, 2002; 8(2): 305 - 313. [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Park, S. Y. Lee, H.-S. Jeon, N. C. Bae, S. C. Chae, S. Joo, C. H. Kim, J.-H. Park, S. Kam, I. S. Kim, et al. Polymorphism of the DNA Repair Gene XRCC1 and Risk of Primary Lung Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 23 - 27. [Abstract] [Full Text]
|
|
|
|
|
|
H. H. Nelson, K. T. Kelsey, L. A. Mott, and M. R. Karagas The XRCC1 Arg399Gln Polymorphism, Sunburn, and Non-melanoma Skin Cancer: Evidence of Gene-Environment Interaction Cancer Res., January 1, 2002; 62(1): 152 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Park, J. Stoehlmacher, W. Zhang, D. D. Tsao-Wei, S. Groshen, and H.-J. Lenz A Xeroderma Pigmentosum Group D Gene Polymorphism Predicts Clinical Outcome to Platinum-based Chemotherapy in Patients with Advanced Colorectal Cancer Cancer Res., December 1, 2001; 61(24): 8654 - 8658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Seker, D. Butkiewicz, E. D. Bowman, M. Rusin, M. Hedayati, L. Grossman, and C. C. Harris Functional Significance of XPD Polymorphic Variants: Attenuated Apoptosis in Human Lymphoblastoid Cells with the XPD 312 Asp/Asp Genotype Cancer Res., October 1, 2001; 61(20): 7430 - 7434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. David-Beabes, R. M. Lunn, and S. J. London No Association between the XPD (Lys751G1n) Polymorphism or the XRCC3 (Thr241Met) Polymorphism and Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 911 - 912. [Full Text] [PDF]
|
|